Upgrade to SI Premium - Free Trial

Form 3 Co-Diagnostics, Inc. For: Sep 02 Filed by: Bohrer Daniel

September 14, 2026 6:50 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Bohrer Daniel
(Last) (First) (Middle)
2401 S. FOOTHILL DR, STE. D
(Street)
SALT LAKE CITY UT 84109
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/02/2026 		3. Issuer Name and Ticker or Trading Symbol
Co-Diagnostics, Inc. [ CODX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP of Finance & Accounting
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 3,657 (1)
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 2,722 unvested Restricted stock units (RSUs) awarded to the Reporting Person pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan comprised of 2,500 awarded on April 26, 2024 and 2,834 awarded on August 11, 2025, of which 1,667 and 945, respectively, previously vested. Vesting of April 26, 2024 award occurs in equal amounts every six months beginning November 23, 2024 and ending on May 23, 2027. Vesting of August 11, 2025 award occurs in equal amounts every six months beginning November 23, 2025 and ending on May 23, 2028.
/s/ Daniel Bohrer 09/14/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings